The use of generic medication in epilepsy: A review of potential issues and challenges
- 31 March 2009
- journal article
- review article
- Published by Elsevier in European Journal of Paediatric Neurology
- Vol. 13 (2) , 87-92
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Clinical consequences of generic substitution of lamotrigine for patients with epilepsyNeurology, 2008
- Compulsory Generic Switching of Antiepileptic Drugs: High Switchback Rates to Branded Compounds Compared with Other Drug ClassesEpilepsia, 2007
- Uncontrolled epilepsy following discontinuation of antiepileptic drugs in seizure-free patients: a review of current clinical experienceActa Neurologica Scandinavica, 2005
- Development of mental health dysfunction in childhood epilepsyBrain and Development, 2005
- The bioequivalence and therapeutic efficacy of generic versus brand-name psychoative drugsClinical Therapeutics, 2003
- Change in oxcarbazepine (Trileptal(R)) formulation is associated with more side effects and higher blood concentrationsJournal of Neurology, Neurosurgery & Psychiatry, 2001
- The cost of epilepsy in the United Kingdom: An estimation based on the results of two population-based studiesEpilepsy Research, 1994
- Bioavailability and dissolution of proprietary and generic formulations of phenytoin.Journal of Neurology, Neurosurgery & Psychiatry, 1992
- Increased seizure frequency with generic primidone1987
- Generic Equivalents: Issues and ConcernsThe Journal of Clinical Pharmacology, 1986